Molecular basis of basal cell carcinoma
- PMID: 28954101
- PMCID: PMC5595599
- DOI: 10.1590/abd1806-4841.20176544
Molecular basis of basal cell carcinoma
Abstract
Basal cell carcinoma is the most common cancer, presenting low mortality but high morbidity, and it has as risk factor exposure to sunlight, especially UVB spectrum. The most important constitutional risk factors for basal cell carcinoma development are clear phototypes (I and II, Fitzpatrick classification), family history of basal cell carcinoma (30-60%), freckles in childhood, eyes and light hair. The environmental risk factor better established is exposure to ultraviolet radiation. However, different solar exposure scenarios probably are independent risk factors for certain clinical and histological types, topographies and prognosis of this tumor, and focus of controversy among researchers. Studies confirm that changes in cellular genes Hedgehog signaling pathway are associated with the development of basal cell carcinoma. The cellular Hedgehog signaling pathway is activated in organogenesis, but is altered in various types of tumors.
Conflict of interest statement
Conflict of interest: none.
Similar articles
-
[Basal cell carcinoma. Molecular genetics and unusual clinical features].Hautarzt. 2007 May;58(5):406-11. doi: 10.1007/s00105-007-1324-y. Hautarzt. 2007. PMID: 17440702 Review. German.
-
Epidemiology of basal cell carcinoma.An Bras Dermatol. 2011 Mar-Apr;86(2):292-305. doi: 10.1590/s0365-05962011000200013. An Bras Dermatol. 2011. PMID: 21603813 Review. English, Portuguese.
-
Relationship between sunlight exposure and a key genetic alteration in basal cell carcinoma.J Natl Cancer Inst. 1996 Mar 20;88(6):349-54. doi: 10.1093/jnci/88.6.349. J Natl Cancer Inst. 1996. PMID: 8609643
-
Basal cell carcinoma and the carcinogenic role of aberrant Hedgehog signaling.Future Oncol. 2010 Jun;6(6):1003-14. doi: 10.2217/fon.10.49. Future Oncol. 2010. PMID: 20528237 Review.
-
Ultraviolet damage, DNA repair and vitamin D in nonmelanoma skin cancer and in malignant melanoma: an update.Adv Exp Med Biol. 2014;810:208-33. doi: 10.1007/978-1-4939-0437-2_12. Adv Exp Med Biol. 2014. PMID: 25207368 Review.
Cited by
-
Review of recent advances in managing periocular skin malignancies.Front Oncol. 2024 Mar 4;14:1275930. doi: 10.3389/fonc.2024.1275930. eCollection 2024. Front Oncol. 2024. PMID: 38500654 Free PMC article. Review.
-
Basal Cell Carcinoma and its Impact on Different Anatomical Regions.Curr Health Sci J. 2021 Jan-Mar;47(1):75-83. doi: 10.12865/CHSJ.47.01.12. Epub 2021 Mar 31. Curr Health Sci J. 2021. PMID: 34211751 Free PMC article.
-
Targeted Drug Delivery in Periorbital Non-Melanocytic Skin Malignancies.Bioengineering (Basel). 2024 Oct 15;11(10):1029. doi: 10.3390/bioengineering11101029. Bioengineering (Basel). 2024. PMID: 39451404 Free PMC article. Review.
-
Exploring the Role of Symptom Diversity in Facial Basal Cell Carcinoma: Key Insights into Preoperative Quality of Life and Disease Progression.Cancers (Basel). 2025 Jan 4;17(1):138. doi: 10.3390/cancers17010138. Cancers (Basel). 2025. PMID: 39796765 Free PMC article.
-
Angiotensinogen, Angiotensin-Converting Enzyme, and Chymase Gene Polymorphisms as Biomarkers for Basal Cell Carcinoma Susceptibility.Adv Exp Med Biol. 2023;1423:175-180. doi: 10.1007/978-3-031-31978-5_14. Adv Exp Med Biol. 2023. PMID: 37525041
References
-
- Bahner JD, Bordeaux JS. Non melanoma skin cancers: Photodynamic therapy, cryotherapy, 5 fluorouracil, imiquimod, diclofenac, or what? Facts and controversies. Clin Dermatol. 2013;31:792–798. - PubMed
-
- Chinem VP, Miot HA. Epidemiology of basal cell carcinoma. An Bras Dermatol. 2011;86:292–305. - PubMed
-
- Sociedade Brasileira de Dermatologia SBD Perfil nosológico das consultas dermatológicas no Brasil. An Bras Dermatol. 2006;81:549–558.
-
- Roewert-Huber J, Lange-Asschenfeldt B, Stockfleth E, Kerl H. Epidemiology and aetiology of basal cell carcinoma. Br J Dermatol. 2007;157:47–51. - PubMed
-
- Hoban PR, Ramachandran S, Strange RC. Environment, phenotype and genetics: risk factors associated with BCC of the skin. Expert Rev Anticancer Ther. 2002;2:570–579. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical